ADX-324 Dose Level 2

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)NCT07428499ADRXPhase 3Recruiting2030-06-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.